Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced <i>KRAS</i>-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Cancer Research and Treatment|October 4, 2021
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung CancerShinkyo Yoon, Hannah Yang, Hyun-Min Ryu, et al.
Translational Lung Cancer Research|March 11, 2026
Molecular epidemiology and outcomes of <i>EGFR</i> exon 20 insertion in Korean patients with non-small cell lung cancerShinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.
Cancer Research|June 28, 2018
Enhanced Glycolysis Supports Cell Survival in EGFR-Mutant Lung Adenocarcinoma by Inhibiting Autophagy-Mediated EGFR DegradationJi Hye Kim, Boas Nam, Yun Jung Choi, et al.
Scientific Reports|July 1, 2024
Comparison of digital and analog [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT for detecting post-prostatectomy biochemical recurrence in prostate cancer patients: a prospective studyYong-Il Kim, Dong Yun Lee, Changhwan Sung, et al.
American Journal of Cancer Research|September 10, 2019
Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutationsJunyoung Choi, Shinkyo Yoon, Deokhoon Kim, et al.
American Journal of Cancer Research|October 12, 2020
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancerJunyoung Choi, Hee Jin Lee, Shinkyo Yoon, et al.
JNCI Cancer Spectrum|April 16, 2024
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrationsAndrea Necchi, Rodryg Ramlau, Alejandro Falcón González, et al.
Cancer Chemotherapy and Pharmacology|June 10, 2017
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancerSungwoo Park, Byung Woog Kang, Soo Jung Lee, et al.
Clinical Lung Cancer|May 23, 2015
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative ResectionChanghoon Yoo, Shinkyo Yoon, Dae Ho Lee, et al.
Pageof 9